Evidence map›Paper›PMID 39796036›Full record

ArticleInternational journal of molecular sciences2024

TH301 Emerges as a Novel Anti-Oncogenic Agent for Human Pancreatic Cancer Cells: The Dispensable Roles of p53, CRY2 and BMAL1 in TH301-Induced

Danae Farmakis, Dimitrios J Stravopodis, Anastasia Prombona

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Targeting Cryptochromes in Chronic Diseases.Cell biology international · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danae FarmakisSection of Cell Biology and Biophysics, Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis, Zografou, 157 01 Athens, Greece.
Dimitrios J StravopodisSection of Cell Biology and Biophysics, Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), Panepistimiopolis, Zografou, 157 01 Athens, Greece.ORCID 0000-0002-9535-2134
Anastasia PrombonaLaboratory of Chronobiology, Institute of Biosciences and Applications (IBA), National Centre for Scientific Research (NCSR) "Demokritos", 153 41 Aghia Paraskevi, Greece.ORCID 0000-0002-1924-6524

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsARNTL Transcription FactorsCarcinoma, Pancreatic DuctalCryptochromesCyclin-Dependent Kinase Inhibitor p21Pancreatic NeoplasmsTumor Suppressor Protein p53ApoptosisAutophagyCell Line, TumorCell ProliferationCell SurvivalCircadian ClocksGene Expression Regulation, NeoplasticHumansUp-RegulationAntineoplastic AgentsARNTL Transcription FactorsBMAL1 protein, humanCDKN1A protein, humanCRY2 protein, humanCryptochromesCyclin-Dependent Kinase Inhibitor p21TP53 protein, humanTumor Suppressor Protein p53apoptosisautophagyBMAL1CDKN1Acircadian clockCRY2p21CIP1/WAF1p53PDACTH301

Identifiers

PMID39796036
PMCPMC11720130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.